112 related articles for article (PubMed ID: 2369938)
1. Relationship of thrombin generation to peripheral blast cell count in patients with acute myeloblastic leukemia (AML).
Scharf RE; Schneider W
Eur J Haematol; 1990 May; 44(5):273-6. PubMed ID: 2369938
[TBL] [Abstract][Full Text] [Related]
2. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
3. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
Gugliotta L; ViganĂ² S; D'Angelo A; Guarini A; Tura S; Mannucci PM
Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation in acute promyelocytic leukemia.
Bauer KA; Rosenberg RD
Blood; 1984 Oct; 64(4):791-6. PubMed ID: 6592007
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
6. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
Wanitpongpun C; Utchariyaprasit E; Owattanapanich W; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Nakhakes C; Limvorapitak W; Kanitsap N; Prayongratana K; Sriswasdi C
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e635-e643. PubMed ID: 33926829
[TBL] [Abstract][Full Text] [Related]
7. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.
Lee HJ; Park HJ; Kim HW; Park SG
Blood Res; 2013 Dec; 48(4):250-3. PubMed ID: 24466548
[TBL] [Abstract][Full Text] [Related]
8. Measurement of fibrinopeptide A in human blood.
Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
[TBL] [Abstract][Full Text] [Related]
9. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
10. Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity.
Myers TJ; Rickles FR; Barb C; Cronlund M
Blood; 1981 Mar; 57(3):518-25. PubMed ID: 6936055
[TBL] [Abstract][Full Text] [Related]
11. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
Soma M; Maeda Y; Kasakura S; Yabe H
Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.
Rodeghiero F; Castaman G; Soffiati G; Quaglio R; Castronovo S; Cortesi S; Dini E
Blut; 1989 Aug; 59(2):177-83. PubMed ID: 2765677
[TBL] [Abstract][Full Text] [Related]
13. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation in acute myeloblastic leukemia.
Scharf RE; Stoffels U; Schneider W
Haematol Blood Transfus; 1990; 33():357-61. PubMed ID: 2323642
[No Abstract] [Full Text] [Related]
15. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
[TBL] [Abstract][Full Text] [Related]
16. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
[TBL] [Abstract][Full Text] [Related]
17. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.
Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE
Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792
[TBL] [Abstract][Full Text] [Related]
18. Fibrinopeptide A during normal pregnancy.
Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
[TBL] [Abstract][Full Text] [Related]
19. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
[TBL] [Abstract][Full Text] [Related]
20. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]